Through their acquisition, MedLife Group reaches a portfolio of 28 acquired companies.
Today MedLife Medical System has announced that is has acquired a majority stake (75%) in Pharmachem, making this their largest acquisition of the year and the first in the pharma sector. Pharmachem is known for their drug distribution services and has a strong warehouse network in Bucharest and in the entire country. In 2019, the company reached a turnover of RON 83.4m (+30% YoY). Through their acquisition, MedLife reaches a portfolio of 28 acquired companies.
MedLife believes that pharma sector will have an important role in the economic recovery of Romania as well as the population’s health maintenance in the next years, justifying their purchase. With the integration of Pharmachem into MedLife group, they plan to optimize the purchasing system at group level through their own network of pharmacies and hospitals. Furthermore, they plan to develop clickpharm.ro, an online pharmacy area, as well as other digitalization projects that will bring the right medicine closer to the patient, consistent with their observations of the consumers’ changing preferences during the pandemic.
For the next period, MedLife representatives intend to develop the acquisition program and expand investments. They are also targeting other transactions at the end of this year. And, on this line, once the named transactions will be completed and current transaction will be evaluated and approved by the Competition Council, they will be the first private medical company in Romania that exceeds EUR 250m in turnover.